John D. Quisel - 18 Feb 2025 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
Issuer symbol
IRON
Transactions as of
18 Feb 2025
Net transactions value
-$304,229
Form type
4
Filing time
20 Feb 2025, 19:27:58 UTC
Previous filing
12 Feb 2025
Next filing
08 Apr 2025

Key filing fact

John D. Quisel filed Form 4 for Disc Medicine, Inc. (IRON) on 20 Feb 2025.

Key facts

  • This page summarizes John D. Quisel's Form 4 filing for Disc Medicine, Inc. (IRON).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 20 Feb 2025, 19:27.

Change

  • Previous filing in this sequence was filed on 12 Feb 2025.
  • Current net transaction value: -$304,229.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

IRON transaction

Common Stock

Sale

Transaction value
$304,229
Shares
-5,574
Change %
-3.5%
Price
$54.58
Shares after
154,828
Date
18 Feb 2025
Ownership
Direct
Footnotes
F1
An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units granted on January 10, 2024 and previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .